{"id":58241,"date":"2024-02-27T18:24:42","date_gmt":"2024-02-27T18:24:42","guid":{"rendered":"https:\/\/medsname.com\/cosart-h\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"cosart-h","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/cosart-h\/","title":{"rendered":"Cosart H"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Cosart H?<\/h3>\n<p style=\"margin:0;\"><strong>Cosart H<\/strong> egy <strong>50\/12.5 mg fixed-dose tablet<\/strong> of losartan 50 mg and <strong>hidroklorotiazid<\/strong> from Abbott Healthcare &mdash; a <strong>m\u00e1sodik l\u00e9p\u00e9sben alkalmazott antihipertenz\u00edv kombin\u00e1ci\u00f3<\/strong> olyan betegek sz\u00e1m\u00e1ra, akiknek v\u00e9rnyom\u00e1sa nem szab\u00e1lyozott <a href=\"https:\/\/medsbase.com\/hu\/losar\/\">Losar<\/a> (losartan monotherapy) alone. Adding a thiazide diuretic typically yields an additional <strong>5-10 Hgmm szisztol\u00e9s v\u00e9rnyom\u00e1scs\u00f6kken\u00e9st eredm\u00e9nyez<\/strong> az ARB monoter\u00e1pi\u00e1hoz k\u00e9pest. A k\u00e9t \u00f6sszetev\u0151 <strong>kieg\u00e9sz\u00edt\u0151 mechanizmusokon kereszt\u00fcl hat<\/strong> (az ARB blokkolja az angiotenzin-II receptort; a HCTZ n\u00e1triumot cs\u00f6kkent \u00e9s enyhe volumencs\u00f6kken\u00e9st id\u00e9z el\u0151), \u00e9s <strong>k\u00f6lcs\u00f6n\u00f6sen kiegyenl\u00edtett mell\u00e9khat\u00e1sprofillal rendelkeznek<\/strong> \u2014 a HCTZ cs\u00f6kkenti a k\u00e1liumot, m\u00edg az ARB emeli azt, \u00edgy a kombin\u00e1ci\u00f3 kev\u00e9sb\u00e9 val\u00f3sz\u00edn\u0171, hogy hipokal\u00e9mi\u00e1t vagy hyperkal\u00e9mi\u00e1t okozzon, mint b\u00e1rmelyik szer \u00f6nmag\u00e1ban azonos d\u00f3zisban. Tipikus adagol\u00e1s: napi egyszer egy tabletta. <strong>Abszol\u00fat kontraindik\u00e1ci\u00f3 terhess\u00e9g alatt<\/strong> (mindk\u00e9t \u00f6sszetev\u0151), <strong>anuria vagy s\u00falyos veseel\u00e9gtelens\u00e9g (eGFR &lt;30)<\/strong>, <strong>tiazid (szulfonamid) t\u00fal\u00e9rz\u00e9kenys\u00e9g<\/strong>, \u00e9s <strong>t\u00fcnetes hyponatraemia<\/strong>. A kezel\u00e9s sor\u00e1n figyelemmel kell k\u00eds\u00e9rni a k\u00e1lium, n\u00e1trium, ur\u00e1t \u00e9s kreatinin szintj\u00e9t.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<h2 class=\"wp-block-heading\">What Is Cosart H?<\/h2>\n<p>Cosart H is an oral fixed-dose combination tablet supplying <strong>losartan 50 mg<\/strong> \u00e9s <strong>\u00e9s hydrochlorothiazide (HCTZ)<\/strong> in a single pill, made by Abbott Healthcare and supplied in 30-180 tablets. It combines two first-line antihypertensive drug classes in a ratio chosen for most patients who have progressed beyond ARB monotherapy. Losartan is the <strong>first ARB approved for clinical use<\/strong> (DuPont Merck 1995; originator brand Cozaar). Half-life ~2 hours for the parent drug and 6-9 hours for the active metabolite E-3174 (generated by CYP2C9 and CYP3A4).<\/p>\n<p>A hydrochlorothiazide (HCTZ) egy tiazid diuretikum, amelyet 1959-ben vezettek be (MSD, HydroDiuril n\u00e9ven). Ma is az egyik leggyakrabban fel\u00edrt antihipertenz\u00edv gy\u00f3gyszer vil\u00e1gszerte, \u00e9s a <strong>negyedik ir\u00e1nyelv \u00e1ltal aj\u00e1nlott els\u0151vonalbeli oszt\u00e1ly<\/strong> a hypertonia kezel\u00e9s\u00e9ben az ARB-k, ACE-g\u00e1tl\u00f3k \u00e9s kalciumcsatorna-blokkol\u00f3k mellett.<\/p>\n<h2 class=\"wp-block-heading\">Mi\u00e9rt kombin\u00e1lj\u00e1k az ARB-t tiaziddal?<\/h2>\n<p>A hypertoni\u00e1t ritk\u00e1n lehet egyetlen gy\u00f3gyszerrel c\u00e9lzott d\u00f3zisban kontroll\u00e1lni. Az olyan vizsg\u00e1latok, mint az ALLHAT, ACCOMPLISH \u00e9s ASCOT meg\u00e1llap\u00edtott\u00e1k, hogy <strong>a legt\u00f6bb hypertoni\u00e1s betegnek k\u00e9t vagy h\u00e1rom k\u00fcl\u00f6nb\u00f6z\u0151 oszt\u00e1lyba tartoz\u00f3 szerre van sz\u00fcks\u00e9ge<\/strong> az ir\u00e1nyelvi v\u00e9rnyom\u00e1s-c\u00e9lok el\u00e9r\u00e9s\u00e9hez (&lt;140\/90 a legt\u00f6bb feln\u0151ttn\u00e9l, &lt;130\/80 diab\u00e9teszesekn\u00e9l \u00e9s CKD-s betegekn\u00e9l). Az ARB + tiazid az egyik h\u00e1rom bizony\u00edt\u00e9kokon alapul\u00f3 k\u00e9tgy\u00f3gyszeres kombin\u00e1ci\u00f3 (a m\u00e1sik kett\u0151 az ARB + CCB \u00e9s CCB + tiazid).<\/p>\n<p>The two components of Cosart H complement each other on <strong>n\u00e9gy farmakol\u00f3giai tengely<\/strong>:<\/p>\n<ul>\n<li><strong>Kieg\u00e9sz\u00edt\u0151 v\u00e9rnyom\u00e1scs\u00f6kkent\u0151 mechanizmusok.<\/strong> Az ARB g\u00e1tolja az \u00e9rsz\u0171k\u00fcletet \u00e9s az aldoszteron \u00e1ltal kiv\u00e1ltott n\u00e1triumretenci\u00e1t; a HCTZ cs\u00f6kkenti a teljes testn\u00e1triumot \u00e9s enyhe t\u00e9rfogatcs\u00f6kken\u00e9st okoz. Addit\u00edv v\u00e9rnyom\u00e1scs\u00f6kken\u00e9s (\u00e1ltal\u00e1ban 5-10 Hgmm szisztol\u00e9s az ARB monoter\u00e1pi\u00e1hoz k\u00e9pest).<\/li>\n<li><strong>RAAS ellenszab\u00e1lyoz\u00e1s.<\/strong> A tiazidok aktiv\u00e1lj\u00e1k a renin-angiotenzin-aldoszteron rendszert a n\u00e1triumvesztes\u00e9g kompenz\u00e1l\u00e1s\u00e1ra \u2013 ez \u00e1ltal\u00e1ban tomp\u00edtja a hat\u00e1sukat. Az AT<sub>1<\/sub> receptor blokkol\u00e1sa ARB-val <strong>megakad\u00e1lyozza ezt a kompenz\u00e1l\u00f3 aktiv\u00e1l\u00e1st<\/strong> \u00e9s felszabad\u00edtja a tiazid teljes antihipertenz\u00edv hat\u00e1s\u00e1t.<\/li>\n<li><strong>K\u00e1liumegyens\u00faly.<\/strong> A HCTZ k\u00e1liumot vesz\u00edt a distalis tubuluson kereszt\u00fcl (klasszikus hipokal\u00e9mia kock\u00e1zat). Az ARB-k n\u00f6velik a k\u00e1liumot az aldoszteron \u00e1ltal medi\u00e1lt k\u00e1lium\u00fcr\u00edt\u00e9s g\u00e1tl\u00e1s\u00e1val. A kombin\u00e1ci\u00f3 ez\u00e9rt fiziol\u00f3gi\u00e1sabb k\u00e1liumszinten m\u0171k\u00f6dik, mint b\u00e1rmelyik szer \u00f6nmag\u00e1ban \u2013 klinikailag kevesebb hipokal\u00e9mia epiz\u00f3d figyelhet\u0151 meg hurokdiuretikumokkal t\u00f6rt\u00e9n\u0151 egy\u00fcttes kezel\u00e9skor, \u00e9s kevesebb klinikailag jelent\u0151s hyperkal\u00e9mia, mint ARB monoter\u00e1pi\u00e1n\u00e1l.<\/li>\n<li><strong>T\u00e9rfogat-aktiv\u00e1l\u00f3 ellenszab\u00e1lyoz\u00e1s.<\/strong> Az ARB \u00e1ltal induk\u00e1lt vazodilat\u00e1ci\u00f3 n\u00e1triumretenti\u00f3t v\u00e1lthat ki s\u00f3\u00e9rz\u00e9keny betegekben (ez a klasszikus oka a v\u00e9rnyom\u00e1scs\u00f6kken\u00e9s \u201celt\u0171n\u00e9s\u00e9nek\u201d a ter\u00e1pia hetei ut\u00e1n). A HCTZ \u00e1ltal okozott natriur\u00e9zia megszak\u00edtja ezt a retenci\u00f3osk\u00f6rt.<\/li>\n<\/ul>\n<p>Losartan is <strong>uniquely uricosuric among ARBs<\/strong> &mdash; it lowers serum uric acid by inhibiting the URAT1 transporter in the proximal tubule. This is clinically important in this combination, because <strong>HCTZ raises serum uric acid<\/strong> by competing for the same excretory pathway. The losartan-HCTZ combination is therefore <strong>the preferred ARB+thiazide pairing for patients with gout, hyperuricaemia, or who are sensitive to thiazide-induced urate rises<\/strong>.<\/p>\n<p><strong>\u2014 300 mg irbesartan 20%-kal cs\u00f6kkentette a szerum kreatinin megdupl\u00e1z\u00f3d\u00e1s\u00e1t, v\u00e9gs\u0151 st\u00e1dium\u00fa veseel\u00e9gtelens\u00e9get vagy hal\u00e1lt 1715 2-es t\u00edpus\u00fa diab\u00e9teszes betegben nyilv\u00e1nval\u00f3 nephropathi\u00e1val.<\/strong> The <strong>LIFE vizsg\u00e1lat (2002)<\/strong> used losartan with HCTZ add-on as its active arm, demonstrating a 13% reduction in stroke, cardiovascular death, and myocardial infarction versus atenolol-based therapy in hypertensive patients with left-ventricular hypertrophy. RENAAL (2001) established renoprotection in type 2 diabetic nephropathy.<\/p>\n<h2 class=\"wp-block-heading\">D\u00f3zis \u00e9s titr\u00e1l\u00e1s<\/h2>\n<p><strong>Standard adag:<\/strong> one 50\/12.5 mg tablet once daily, typically in the morning (HCTZ causes a mild diuresis; evening dosing can disrupt sleep with night-time urination).<\/p>\n<p><strong>When to start Cosart H:<\/strong><\/p>\n<ul>\n<li>BP not controlled on losartan 50 mg monotherapy after 4-6 weeks at target dose<\/li>\n<li>ACE-g\u00e1tl\u00f3\/HCTZ kombin\u00e1ci\u00f3r\u00f3l val\u00f3 \u00e1tt\u00e9r\u00e9s, ha az ACE-g\u00e1tl\u00f3 k\u00f6h\u00f6g\u00e9st okozott<\/li>\n<li>ha a v\u00e9rnyom\u00e1s tov\u00e1bbra is ellen\u0151rizetlen marad 4-6 h\u00e9t ut\u00e1n a kezd\u0151 fix kombin\u00e1ci\u00f3s tablett\u00e1n, egy er\u0151sebb fix kombin\u00e1ci\u00f3s tablett\u00e1ra lehet v\u00e1ltani (a legt\u00f6bb gy\u00e1rt\u00f3 50\/12,5, 100\/12,5, 80\/12,5, 160\/12,5 \u00e9s 160\/25 kombin\u00e1ci\u00f3kat k\u00edn\u00e1l a megfelel\u0151 ARB \u00e9s HCTZ kombin\u00e1ci\u00f3j\u00e1ban). Alternat\u00edvak\u00e9nt adjunk hozz\u00e1 egy harmadik oszt\u00e1lyt \u2014 \u00e1ltal\u00e1ban egy<\/li>\n<\/ul>\n<p><strong>Titr\u00e1l\u00e1s:<\/strong> kalciumcsatorna-blokkol\u00f3t (amlodipin) <a href=\"https:\/\/medsbase.com\/hu\/amlode\/\">calcium-channel blocker (amlodipine)<\/a>.<\/p>\n<p><strong>Monitoroz\u00e1si \u00fctemterv:<\/strong><\/p>\n<ul>\n<li><strong>Alapvizsg\u00e1lat:<\/strong> karbamid, elektrolitok (n\u00e1trium, k\u00e1lium), kreatinin, eGFR, sz\u00e9rum-ur\u00e1t, \u00e9homi v\u00e9rcukor, lipidek. Otthoni vagy rendel\u0151i v\u00e9rnyom\u00e1sm\u00e9r\u00e9s.<\/li>\n<li><strong>1-2 h\u00e9ttel a kezd\u00e9s vagy adagv\u00e1ltoztat\u00e1s ut\u00e1n:<\/strong> ism\u00e9telt U&amp;E. V\u00e1rhat\u00f3 kis kreatininemelked\u00e9s (ak\u00e1r 30% is elfogadhat\u00f3), kis n\u00e1triumcs\u00f6kken\u00e9s (1-3 mmol), kis ur\u00e1temelked\u00e9s (r\u00e9szben kompenz\u00e1l\u00f3dik a losart\u00e1nt tartalmaz\u00f3 k\u00e9sz\u00edtm\u00e9nyekben). A k\u00e1lium jellemz\u0151en stabil marad a norm\u00e1lis tartom\u00e1nyban.<\/li>\n<li><strong>4-6 h\u00e9t:<\/strong> v\u00e9rnyom\u00e1s-ellen\u0151rz\u00e9s a v\u00e1lasz \u00e9rt\u00e9kel\u00e9s\u00e9re; ism\u00e9telt U&amp;E, ha kor\u00e1bbi id\u0151pontban elektrolit-egyens\u00falyzavar mer\u00fclt fel.<\/li>\n<li><strong>Folyamatos k\u00f6vet\u00e9s:<\/strong> \u00e9ves U&amp;E, ur\u00e1t, v\u00e9rcukor \u00e9s lipidek, ha stabil az \u00e1llapot. Otthoni v\u00e9rnyom\u00e1sm\u00e9r\u00e9s hetente k\u00e9tszer.<\/li>\n<li><strong>\u00c1ll\u00edtsa le \u00e9s vizsg\u00e1lja tov\u00e1bb, ha:<\/strong> t\u00fcnetes hiponatr\u00e9mia (zavarts\u00e1g, h\u00e1nyinger, letargia; sz\u00e9rum-Na &lt;130), k\u00e1lium 5,5, kreatininemelked\u00e9s &gt;30%, \u00faj vagy s\u00falyosbod\u00f3 k\u00f6szv\u00e9ny, t\u00fal\u00e9rz\u00e9kenys\u00e9gi ki\u00fct\u00e9s.<\/li>\n<\/ul>\n<p><strong>Megsz\u00fcntet\u00e9s:<\/strong> nincs elvon\u00e1si szindr\u00f3ma, de a hirtelen abbahagy\u00e1s napok alatt fokozatos v\u00e9rnyom\u00e1semelked\u00e9st okoz. Fokozatos cs\u00f6kkent\u00e9s alacsonyabb er\u0151ss\u00e9g\u0171 kombin\u00e1ci\u00f3ra v\u00e1lt\u00e1ssal vagy ARB-monoter\u00e1pi\u00e1ra visszat\u00e9r\u00e9ssel v\u00e9rnyom\u00e1smonitoroz\u00e1s mellett.<\/p>\n<h2 class=\"wp-block-heading\">Mell\u00e9khat\u00e1sok<\/h2>\n<p>A mell\u00e9khat\u00e1sok \u00e1tfed\u00e9sben vannak mindk\u00e9t \u00f6sszetev\u0151 gy\u00f3gyszer\u00e9vel. A kombin\u00e1ci\u00f3 \u00e1ltal\u00e1ban <strong>jobban toler\u00e1lhat\u00f3<\/strong> , mint b\u00e1rmelyik \u00f6sszetev\u0151 a maxim\u00e1lis monoter\u00e1pi\u00e1s d\u00f3zisban, mivel a fix kombin\u00e1ci\u00f3kban haszn\u00e1lt d\u00f3zisok alacsonyabbak, mint a cs\u00facs monoter\u00e1pi\u00e1s d\u00f3zisok.<\/p>\n<p><strong>Gyakori (&gt;1%-ban el\u0151fordul\u00f3):<\/strong><\/p>\n<ul>\n<li>Sz\u00e9d\u00fcl\u00e9s, ortosztatikus hypot\u00f3nia (\u00e1ltal\u00e1ban enyhe; gyakoribb az els\u0151 1-2 h\u00e9tben)<\/li>\n<li>Enyhe diur\u00e9zis \u2014 fokozott vizel\u00e9s az els\u0151 n\u00e9h\u00e1ny napban, \u00e1ltal\u00e1ban a t\u00e9rfogat-egyens\u00faly be\u00e1llt\u00e1val cs\u00f6kken<\/li>\n<li>Enyhe hiponatr\u00e9mia vagy hipokali\u00e9mia \u00e9rz\u00e9keny betegekben<\/li>\n<li>V\u00e1rhat\u00f3 kis kreatininemelked\u00e9s (ak\u00e1r 30%)<\/li>\n<li>F\u00e1radts\u00e1g, fejf\u00e1j\u00e1s, nasopharyngitis<\/li>\n<li>Hyperuricaemia (\u00e1ltal\u00e1ban t\u00fcnetmentes; ritk\u00e1n kiv\u00e1lthat k\u00f6szv\u00e9nyt \u2013 kev\u00e9sb\u00e9 val\u00f3sz\u00edn\u0171 losartan-tartalm\u00fa kombin\u00e1ci\u00f3k eset\u00e9n)<\/li>\n<li>F\u00e9ny\u00e9rz\u00e9kenys\u00e9g ki\u00fct\u00e9s (tiazid-hoz kapcsol\u00f3d\u00f3)<\/li>\n<\/ul>\n<p><strong>Ritka, de klinikailag jelent\u0151s:<\/strong><\/p>\n<ul>\n<li><strong>S\u00falyos hyponatraemia<\/strong> \u2014 a kock\u00e1zat legnagyobb id\u0151s n\u0151kn\u00e9l, alacsony s\u00f3tartalm\u00fa \u00e9trend mellett, sz\u00edvel\u00e9gtelens\u00e9g vagy SIADH hajlam eset\u00e9n. Minden \u00faj zavarts\u00e1got, h\u00e1nyingert vagy es\u00e9st vizsg\u00e1ljon meg sz\u00e9rum n\u00e1trium szinttel.<\/li>\n<li><strong>Akut k\u00f6szv\u00e9ny kialakul\u00e1sa<\/strong> \u2014 val\u00f3sz\u00edn\u0171bb valsartan+HCTZ vagy telmisartan+HCTZ eset\u00e9n, mint losartan+HCTZ eset\u00e9n. V\u00e1lt\u00e1s losartan-alap\u00fa kombin\u00e1ci\u00f3ra, ha ism\u00e9tl\u0151dik.<\/li>\n<li><strong>Anyagcsavar-zavar<\/strong> \u2014 roml\u00f3 gl\u00fck\u00f3ztolerancia (5-8 mg\/dL \u00e1tlagos \u00e9homi v\u00e9rcukorszint-emelked\u00e9s), m\u00e9rs\u00e9kelt LDL \u00e9s triglicerid n\u00f6veked\u00e9s. A telmisartan r\u00e9szben ellens\u00falyozza ezt PPAR-\u03b3 aktivit\u00e1s\u00e1n kereszt\u00fcl.<\/li>\n<li><strong>Angioedema<\/strong> \u2014 alacsonyabb ar\u00e1nyban, mint az ACE-g\u00e1tl\u00f3kn\u00e1l, de lehets\u00e9ges. Azonnal sz\u00fcneteltesse; helyettes\u00edtse nem-RAAS szerrel.<\/li>\n<li><strong>Akut veseel\u00e9gtelens\u00e9g t\u00e9rfogat-deplet\u00e1lt \u00e1llapotban vagy k\u00e9toldali veseart\u00e9ria-stenosis eset\u00e9n<\/strong><\/li>\n<li><strong>Pancreatitis<\/strong> \u2014 ritka tiazid-oszt\u00e1ly\u00fa mell\u00e9khat\u00e1s; azonnal sz\u00fcneteltesse b\u00e1rmilyen fels\u0151 hasi f\u00e1jdalom eset\u00e9n lip\u00e1z-emelked\u00e9ssel.<\/li>\n<li><strong>Akut myopia \u00e9s z\u00e1r\u00f3d\u00e1si glauk\u00f3ma<\/strong> \u2014 ritka szulfonamid-oszt\u00e1ly\u00fa reakci\u00f3, \u00e1ltal\u00e1ban az \u00faj szulfonamid kezd\u00e9s\u00e9t\u0151l sz\u00e1m\u00edtott \u00f3r\u00e1kon vagy napokon bel\u00fcl. Szak\u00edtsa meg a kezel\u00e9st \u00e9s keressen s\u00fcrg\u0151sen szemorvosi vizsg\u00e1latot, ha hirtelen f\u00e1jdalmas szem vagy l\u00e1t\u00e1sv\u00e1ltoz\u00e1s l\u00e9p fel.<\/li>\n<li><strong>Trombocitopenia, leukopenia<\/strong> \u2014 ritka tiazid-oszt\u00e1ly\u00fa reakci\u00f3k<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Ellenjavallatok<\/h2>\n<ul>\n<li><strong>Terhess\u00e9g \u2014 ABSZOL\u00daT ellenjavallat minden trimeszterben.<\/strong> Mindk\u00e9t komponens: az ARB-k magzati veseagenesist, oligohidramni\u00f3nt, t\u00fcd\u0151hipopl\u00e1zi\u00e1t okozhatnak; a HCTZ \u00e1tjut a m\u00e9hlep\u00e9nyen \u00e9s magzati vagy \u00fajsz\u00fcl\u00f6ttkori s\u00e1rgas\u00e1got \u00e9s trombocitop\u00e9ni\u00e1t okozhat. V\u00e1ltson \u00e1t <a href=\"https:\/\/medsbase.com\/hu\/labebet\/\">labetalol<\/a>, metildop\u00e1ra vagy nifedipinre a fogantat\u00e1s el\u0151tt.<\/li>\n<li><strong>Anuria vagy s\u00falyos veseel\u00e9gtelens\u00e9g<\/strong> (eGFR &lt;30 mL\/perc\/1,73 m\u00b2<sup>2<\/sup>) \u2014 a HCTZ hat\u00e9konys\u00e1g\u00e1t veszti alacsony GFR mellett, \u00e9s az ARB akut vesek\u00e1rosod\u00e1st okozhat<\/li>\n<li><strong>Tiazid vagy szulfonamid t\u00fal\u00e9rz\u00e9kenys\u00e9g<\/strong><\/li>\n<li><strong>T\u00fcneti hiponatr\u00e9mia (Na &lt;130)<\/strong> alap\u00e1llapotban \u2014 romlani fog<\/li>\n<li><strong>T\u00fcneti hipokal\u00e9mia (K &lt;3,0)<\/strong> vagy hipomagn\u00e9zia alap\u00e1llapotban \u2014 el\u0151sz\u00f6r jav\u00edtsa ki<\/li>\n<li><strong>Hypercalcaemia<\/strong> \u2014 a HCTZ n\u00f6veli a kalciumot a vizeletben t\u00f6rt\u00e9n\u0151 ki\u00fcr\u00fcl\u00e9s cs\u00f6kkent\u00e9s\u00e9vel<\/li>\n<li><strong>S\u00falyos m\u00e1jel\u00e9gtelens\u00e9g<\/strong> (Child-Pugh C) \u2014 elektroliteltol\u00f3d\u00e1s \u00e1ltal kiv\u00e1ltott m\u00e1jenc\u00e9falop\u00e1tia kock\u00e1zata<\/li>\n<li><strong>Angio\u00f6d\u00e9ma el\u0151zm\u00e9ny b\u00e1rmely ACE-g\u00e1tl\u00f3val vagy ARB-val<\/strong> (4 h\u00e9ten bel\u00fcl; hossz\u00fa t\u00e1v\u00fa \u00f3vatos alkalmaz\u00e1s gyakran elfogadhat\u00f3 szakorvosi tan\u00e1cs mellett)<\/li>\n<li><strong>Bilateralis veseart\u00e9ria-sz\u0171k\u00fclet<\/strong><\/li>\n<li><strong>Egyidej\u0171 sacubitril\/valsartan (Entresto)<\/strong> \u2014 36 \u00f3r\u00e1s kimos\u00e1si id\u0151 sz\u00fcks\u00e9ges<\/li>\n<li><strong>Egyidej\u0171 aliskiren haszn\u00e1lata diabetesben vagy kr\u00f3nikus vesebetegs\u00e9gben<\/strong> (ALTITUDE k\u00e1ros hat\u00e1s)<\/li>\n<li><strong>Egyidej\u0171 ACE-g\u00e1tl\u00f3<\/strong> \u2014 ONTARGET k\u00e1ros hat\u00e1s haszon n\u00e9lk\u00fcl<\/li>\n<\/ul>\n<p><strong>Szoptat\u00e1s:<\/strong> A HCTZ a tejbe ker\u00fcl \u00e9s magasabb d\u00f3zisokban g\u00e1tolhatja a lakt\u00e1ci\u00f3t; \u00e1ltal\u00e1ban ker\u00fclik a korasz\u00fcl\u00f6tt sz\u00fcl\u00e9s ut\u00e1ni els\u0151 hetekben. Alternat\u00edv antihipertenz\u00edv szerek (propranolol, nifedipin) el\u0151ny\u00f6sek, ha lehets\u00e9ges.<\/p>\n<h2 class=\"wp-block-heading\">Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<ul>\n<li><strong>L\u00edtium \u2014 KRITIKUS INTERAKCI\u00d3.<\/strong> A tiazidok cs\u00f6kkentik a l\u00edtium vesei clearance-\u00e9t \u00e9s el\u0151id\u00e9zhetik a l\u00edtiumm\u00e9rgez\u00e9st. Ker\u00fclj\u00fck a kombin\u00e1ci\u00f3t, ha lehets\u00e9ges; ha elker\u00fclhetetlen, hetente monitorozzuk a l\u00edtiumszintet az els\u0151 h\u00f3napban \u00e9s cs\u00f6kkents\u00fck a l\u00edtiumd\u00f3zist 25-50%-kal.<\/li>\n<li><strong>NSAID-k \u2014 \u201ctriple whammy\u201d kock\u00e1zat.<\/strong> ARB + diuretikum + NSAID = magy AKI kock\u00e1zat hypovolaemi\u00e1ban vagy egyidej\u0171 betegs\u00e9g eset\u00e9n (fert\u0151z\u00e9s, dehidrat\u00e1ci\u00f3). Cs\u00f6kkents\u00fck az NSAID-k haszn\u00e1lat\u00e1t alkalmi r\u00f6vid t\u00e1v\u00fara; paracetamol el\u0151ny\u00f6sebb.<\/li>\n<li><strong>K\u00e1lium-p\u00f3tl\u00f3 szerek, k\u00e1liumtart\u00f3 diuretikumok (spironolakton, eplerenon, amilorid)<\/strong> \u2014 hyperkalaemia a HCTZ \u00e1ltal okozott k\u00e1liumveszt\u00e9s ellen\u00e9re. Szorosan monitorozni.<\/li>\n<li><strong>Digoxin<\/strong> \u2014 HCTZ \u00e1ltal okozott hypokalaemia fokozza a digoxin toxicit\u00e1s\u00e1t. Monitorozzuk a k\u00e1lium- \u00e9s digoxinszinteket.<\/li>\n<li><strong>Szteroid tabletta<\/strong> \u2014 addit\u00edv hypokalaemia \u00e9s folyad\u00e9kretentio (r\u00e9szben ellens\u00falyozva a tiazid hat\u00e1st)<\/li>\n<li><strong>Amphotericin B, stimul\u00e1l\u00f3 hashajt\u00f3k<\/strong> \u2014 addit\u00edv hypokalaemia kock\u00e1zat<\/li>\n<li><strong>Or\u00e1lis antidiabetikumok, inzulin<\/strong> \u2014 a tiazidok rontj\u00e1k a gl\u00fck\u00f3ztoleranci\u00e1t; a diab\u00e9teszes HbA1c 0,1-0,3%-kal emelkedhet. Kevesebb aggodalomra ad okot telmisartan+HCTZ kombin\u00e1ci\u00f3 eset\u00e9n, mint m\u00e1s ARB+HCTZ kombin\u00e1ci\u00f3kn\u00e1l (a telmisartan PPAR-\u03b3 aktivit\u00e1sa r\u00e9szben ellens\u00falyozza a tiazid hat\u00e1st).<\/li>\n<li><strong>Kolesztiramin \/ kolesztipol<\/strong> \u2014 40-85%-kal cs\u00f6kkenti a HCTZ felsz\u00edv\u00f3d\u00e1s\u00e1t. K\u00fcl\u00f6n\u00edtse az adagol\u00e1st 4 \u00f3r\u00e1val.<\/li>\n<li><strong>Alkohol<\/strong> \u2014 addit\u00edv posztur\u00e1lis hypot\u00f3nia, k\u00fcl\u00f6n\u00f6sen adag be\u00e1ll\u00edt\u00e1skor<\/li>\n<li><strong>Fluconazole, rifampicin<\/strong> &mdash; affect CYP2C9\/3A4 activation of losartan to E-3174 metabolite; may alter BP effect<\/li>\n<li><strong>Egy\u00e9b ACE g\u00e1tl\u00f3k, egy\u00e9b ARB-k, aliskiren<\/strong> \u2014 ne kombin\u00e1lja<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cosart H vs ARB Monotherapy &mdash; When to Step Up<\/h2>\n<p>Cosart H is a <strong>2. l\u00e9pcs\u0151s szer<\/strong>, nem els\u0151 vonalbeli gy\u00f3gyszer. \u00daj, sz\u00f6v\u0151dm\u00e9nyek n\u00e9lk\u00fcli hypertonia eset\u00e9n:<\/p>\n<ol>\n<li><strong>Kezel\u00e9s ind\u00edt\u00e1sa<\/strong> val <a href=\"https:\/\/medsbase.com\/hu\/losar\/\">Losar<\/a> (losartan monotherapy) (or a calcium-channel blocker; or an ACE inhibitor if no ACEi-cough history)<\/li>\n<li><strong>Titr\u00e1l\u00e1s<\/strong> c\u00e9ladag el\u00e9r\u00e9s\u00e9hez 4-6 h\u00e9t alatt<\/li>\n<li><strong>Ha a v\u00e9rnyom\u00e1s tov\u00e1bbra is nem szab\u00e1lyozott<\/strong>, move to Cosart H (ARB + thiazide) <strong>vagy<\/strong> adjunk hozz\u00e1 CCB-t (ARB + CCB). Mindk\u00e9t kombin\u00e1ci\u00f3 bizony\u00edtottan hat\u00e1sos.<\/li>\n<li><strong>Ha a v\u00e9rnyom\u00e1s tov\u00e1bbra is nem szab\u00e1lyozott 4-6 h\u00e9t kombin\u00e1lt kezel\u00e9s ut\u00e1n<\/strong>, v\u00e1ltson h\u00e1rmas kombin\u00e1ci\u00f3ra: ARB + CCB + tiazid<\/li>\n<li><strong>H\u00e1rmas kombin\u00e1ci\u00f3 feletti kezel\u00e9s<\/strong>, adjunk hozz\u00e1 spironolakont (PATHWAY-2 vizsg\u00e1lat bizony\u00edt\u00e9ka rezisztens hypertonia eset\u00e9n) vagy utaljon specialist\u00e1ra tov\u00e1bbi vizsg\u00e1latra (veseart\u00e9ria-stenosis, primer aldosteronizmus, phaeochromocytoma)<\/li>\n<\/ol>\n<p>Patients with uncomplicated stage 2 hypertension (&ge;160\/100) may reasonably start directly on Cosart H &mdash; current AHA\/ACC guidelines prefer early two-drug initiation for severe hypertension over single-drug titration.<\/p>\n<h2 class=\"wp-block-heading\">T\u00e1rol\u00e1s<\/h2>\n<p>Store Cosart H below 25&deg;C in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3 class=\"wp-block-heading\">Is Cosart H a first-line blood-pressure drug?<\/h3>\n<p>Nem \u2014 az ARB\/tiazid fix kombin\u00e1ci\u00f3k <strong>m\u00e1sodik l\u00e9pcs\u0151s szerek<\/strong>. A szok\u00e1sos megk\u00f6zel\u00edt\u00e9s az, hogy ARB monoter\u00e1pi\u00e1val kezdj\u00fck (<a href=\"https:\/\/medsbase.com\/hu\/losar\/\">Losar<\/a> (losartan monotherapy)), titrate to target dose, and move to Cosart H only if BP is not controlled after 4-6 weeks. An exception: stage 2 hypertension (&ge;160\/100) can reasonably start on two-drug therapy directly per AHA\/ACC guidelines.<\/p>\n<h3 class=\"wp-block-heading\">When should I take Cosart H &mdash; morning or evening?<\/h3>\n<p><strong>Reggel<\/strong> a reggeli szed\u00e9s az alap\u00e9rtelmezett. A HCTZ komponens diuretikum \u2014 a bev\u00e9telt k\u00f6vet\u0151en 2-4 \u00f3r\u00e1val n\u00f6veli a vizelet\u00fcr\u00edt\u00e9st. Az esti szed\u00e9s zavarhatja az alv\u00e1st az \u00e9jszakai vizel\u00e9ssel. Egyes betegekn\u00e9l (akik nem mutatnak \u00e9jszakai cs\u00f6kken\u00e9st, kr\u00f3nikus vesebetegs\u00e9g) az esti szed\u00e9s javasolt lehet a reggeli v\u00e9rnyom\u00e1s c\u00e9lz\u00e1s\u00e1ra; besz\u00e9lje meg orvos\u00e1val.<\/p>\n<h3 class=\"wp-block-heading\">Mennyivel sz\u00e1m\u00edthatok t\u00f6bb v\u00e9rnyom\u00e1scs\u00f6kken\u00e9sre az <a href=\"https:\/\/medsbase.com\/hu\/losar\/\">Losar<\/a> (losartan monotherapy) alone?<\/h3>\n<p>Nagyj\u00e1b\u00f3l <strong>hoz k\u00e9pest?<\/strong> on average, measured 4-6 weeks after starting Cosart H. The additive effect comes from blocking the compensatory RAAS activation that normally blunts thiazide monotherapy; that blockade unlocks HCTZ&rsquo;s full effect.<\/p>\n<h3 class=\"wp-block-heading\">My potassium is normal on an ARB &mdash; will it drop on Cosart H?<\/h3>\n<p>A k\u00e1liumom norm\u00e1lis ARB mellett \u2014 cs\u00f6kken az Irovel H hat\u00e1s\u00e1ra? <strong>\u00c1ltal\u00e1ban a norm\u00e1lis tartom\u00e1nyban marad. A tiazid \u00e1ltal okozott k\u00e1liumvesztes\u00e9g<\/strong>. A small number of patients do develop hypokalaemia &mdash; baseline and 1-2 week follow-up U&amp;E is routine. If potassium drops below 3.5, add a potassium-sparing strategy (eplerenone, a potassium-rich diet, or occasionally potassium supplementation) rather than stopping Cosart H.<\/p>\n<h3 class=\"wp-block-heading\">Will Cosart H raise my uric acid or trigger gout?<\/h3>\n<p>Losartan uniquely <strong>cs\u00f6kkenti<\/strong> serum uric acid by inhibiting URAT1 in the proximal tubule, which <strong>partially offsets<\/strong> HCTZ&rsquo;s urate-raising effect. Losartan + HCTZ is the <strong>preferred ARB+thiazide combination for patients with gout or hyperuricaemia<\/strong>. New-onset gout on Cosart H is uncommon but possible in high-risk patients (CKD, male, alcohol, obesity).<\/p>\n<h3 class=\"wp-block-heading\">I have type 2 diabetes &mdash; is Cosart H safe?<\/h3>\n<p>Igen, de tartsa szem el\u0151tt, hogy <strong>a tiazidok enyh\u00e9n rontj\u00e1k a gl\u00fck\u00f3ztoleranci\u00e1t<\/strong> (average fasting-glucose rise 5-8 mg\/dL, HbA1c rise 0.1-0.3%). The BP benefit outweighs this effect in most diabetics, and tighter BP control reduces diabetic kidney and eye complications more than the glucose rise increases them. Monitor HbA1c annually. If diabetic control worsens on Cosart H, ask about switching to <a href=\"https:\/\/medsbase.com\/hu\/telma-h\/\">Telma H<\/a> (telmisartan + HCTZ) kombin\u00e1ci\u00f3ra, amely r\u00e9szben metabolikus v\u00e9d\u0151 hat\u00e1s\u00fa.<\/p>\n<h3 class=\"wp-block-heading\">Can I take ibuprofen with Cosart H?<\/h3>\n<p>A ritka, r\u00f6vid t\u00e1v\u00fa haszn\u00e1lat \u00e1ltal\u00e1ban nem jelent probl\u00e9m\u00e1t. <strong>Kr\u00f3nikus, napi NSAID-szed\u00e9s<\/strong> (ibuprofen, diklofen\u00e1k, naprox\u00e9n) kock\u00e1zatos b\u00e1rmilyen ARB + v\u00edzhajt\u00f3 kombin\u00e1ci\u00f3 mellett \u2014 a \u201ctripla csap\u00e1s\u201d (ARB + v\u00edzhajt\u00f3 + NSAID) akut veseel\u00e9gtelens\u00e9get v\u00e1lthat ki kisz\u00e1rad\u00e1s, fert\u0151z\u00e9s vagy m\u0171t\u00e9t eset\u00e9n. Kr\u00f3nikus f\u00e1jdalom eset\u00e9n haszn\u00e1ljon paracetamolt; gyullad\u00e1s eset\u00e9n besz\u00e9ljen alternat\u00edv\u00e1kat orvos\u00e1val.<\/p>\n<h3 class=\"wp-block-heading\">Can I take Cosart H in pregnancy?<\/h3>\n<p><strong>Nem \u2014 abszol\u00fat kontraindik\u00e1lt.<\/strong> Mindk\u00e9t \u00f6sszetev\u0151 teratog\u00e9n: az ARB magzati veseagenesist \u00e9s oligohidramni\u00f3t okoz; a HCTZ \u00e1tjut a m\u00e9hlep\u00e9nyen \u00e9s magzati vagy \u00fajsz\u00fcl\u00f6ttkori s\u00e1rgas\u00e1got \u00e9s trombocitop\u00e9ni\u00e1t v\u00e1lthat ki. Sz\u00fcl\u0151k\u00e9pes kor\u00fa n\u0151knek megb\u00edzhat\u00f3 fogamz\u00e1sg\u00e1tl\u00e1st kell haszn\u00e1lniuk. Tervezett terhess\u00e9g eset\u00e9n v\u00e1ltson \u00e1t <a href=\"https:\/\/medsbase.com\/hu\/labebet\/\">labetalol<\/a>, metildop\u00e1ra vagy nifedipinre <strong>a fogantat\u00e1s el\u0151tt<\/strong>.<\/p>\n<h3 class=\"wp-block-heading\">Will I need to urinate more at night on Cosart H?<\/h3>\n<p>\u00c1ltal\u00e1ban nem, ha reggel veszi be a tablett\u00e1t. A v\u00edzhajt\u00f3 hat\u00e1s 2-4 \u00f3r\u00e1val a bev\u00e9tele ut\u00e1n \u00e9ri el a cs\u00facsot, \u00e9s est\u00e9re m\u00e1r j\u00f3r\u00e9szt elm\u00falik. Az esti szed\u00e9sre v\u00e1lt\u00f3 betegek gyakran tapasztalnak nokt\u00fari\u00e1t; a reggeli szed\u00e9sre val\u00f3 visszat\u00e9r\u00e9s 1-3 napon bel\u00fcl megoldja ezt.<\/p>\n<h3 class=\"wp-block-heading\">Mi a teend\u0151, ha kihagyok egy adagot?<\/h3>\n<p>Vegye be, amint esz\u00e9be jut, kiv\u00e9ve ha a k\u00f6vetkez\u0151 adag bev\u00e9tele m\u00e1r n\u00e9h\u00e1ny \u00f3r\u00e1n bel\u00fcl van \u2014 ilyenkor hagyja ki a kihagyott adagot \u00e9s folytassa a szok\u00e1sos szed\u00e9si rendet. Ne dupl\u00e1zza meg az adagot. Egy elmulasztott adag nem befoly\u00e1solja jelent\u0151sen a v\u00e9rnyom\u00e1s-szab\u00e1lyoz\u00e1st. Ha t\u00f6bb mint 2 napot kihagy, a v\u00e9rnyom\u00e1sa \u00fajra emelkedni kezd; folytassa a szok\u00e1sos adaggal (nem kell n\u00f6velni).<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Cosart H online?<\/h3>\n<p>You can buy Cosart H (50\/12.5 mg losartan + HCTZ, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n<h2 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 antihipertenz\u00edv szerek a MedsBase-en<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/amlode\/\">Amlode \u2014 Amlodipin 5\/10 mg (CCB)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/losar\/\">Losar \u2014 Losartan 25\/50 mg (monoter\u00e1pia)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/olmesar\/\">Olmesar \u2014 Olmesartan 20\/40 mg (monoter\u00e1pia)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/olmezest-am\/\">Olmezest AM \u2013 Olmesartan + Amlodipine<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/ramcor\/\">Ramcor \u2014 Ramipril (ACE-inhibitor alternat\u00edva)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/telmaheal\/\">Telmaheal \u2014 Telmisartan 20\/40\/80 mg (monoter\u00e1pia)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/high-blood-pressure-medication\/\"><strong>\u00d6sszes magas v\u00e9rnyom\u00e1sra szolg\u00e1l\u00f3 gy\u00f3gyszer b\u00f6ng\u00e9sz\u00e9se<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Orvosi nyilatkozat.<\/strong> Ez az oldal t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti a k\u00e9pzett eg\u00e9szs\u00e9g\u00fcgyi szakember tan\u00e1cs\u00e1t. A hypertonia, sz\u00edvel\u00e9gtelens\u00e9g \u00e9s sz\u00edvritmuszavarok diagnosztiz\u00e1l\u00e1st, monitoroz\u00e1st \u00e9s d\u00f3zis-individualiz\u00e1l\u00e1st ig\u00e9nyelnek orvosi r\u00e9sz\u00e9r\u0151l \u2014 mindig orvosi utas\u00edt\u00e1s szerint haszn\u00e1ljon b\u00e9ta-blokkol\u00f3kat.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/crocin-advance\/\">Crocin Advance<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/asthafen\/\">Asthafen<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/letroheal\/\">Letroheal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/verpin\/\">Verpin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/wysolone\/\">Wysolone<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Cosart H is Abbott&#8217;s fixed-dose losartan 50 mg + HCTZ 12.5 mg tablets \u2014 step-2 antihypertensive combination for patients not controlled on losartan monotherapy. Losartan is uniquely uricosuric among ARBs, partially offsetting HCTZ&#8217;s urate-raising effect \u2014 the preferred ARB+thiazide combination in hypertension with gout or hyperuricaemia. LIFE trial used this combination.<\/p>","protected":false},"featured_media":58242,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3342,3260,3356],"product_tag":[4450,3401,4447],"class_list":{"0":"post-58241","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-general-health","9":"product_cat-heart-blood-pressure","10":"product_cat-high-blood-pressure-medication","11":"product_tag-cosart-h","12":"product_tag-hydrochlorothiazide","13":"product_tag-losartan-potassium","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/58241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=58241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/58242"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=58241"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=58241"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=58241"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=58241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}